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Abstract
Background: Delirium is a serious neuropsychiatric syndrome frequently experienced by palliative care inpatients. This syndrome is 
under-recognized by clinicians. While screening increases recognition, it is not a routine practice.
Aim and design: This systematic review aims to examine methods, quality, and results of delirium prevalence and incidence studies 
in palliative care inpatient populations and discuss implications for delirium screening.
Data sources: A systematic search of the literature identified prospective studies reporting on delirium prevalence and/or incidence 
in inpatient palliative care adult populations from 1980 to 2012. Papers not in English or those reporting the occurrence of symptoms 
not specifically identified as delirium were excluded.
Results: Of the eight included studies, the majority (98.9%) involved participants (1079) with advanced cancer. Eight different 
screening and assessment tools were used. Delirium incidence ranged from 3% to 45%, while delirium prevalence varied, with a 
range of: 13.3%–42.3% at admission, 26%–62% during admission, and increasing to 58.8%–88% in the weeks or hours preceding death. 
Studies that used the Diagnostic and Statistical Manual–Fourth Edition reported higher prevalence (42%–88%) and incidence (40.2%–
45%), while incidence rates were higher in studies that screened participants at least daily (32.8%–45%). Hypoactive delirium was the 
most prevalent delirium subtype (68%–86% of cases).
Conclusion: The prevalence and incidence of delirium in palliative care inpatient settings supports the need for screening. However, 
there is limited consensus on assessment measures or knowledge of implications of delirium screening for inpatients and families. 
Further research is required to develop standardized methods of delirium screening, assessment, and management that are acceptable 
to inpatients and families.
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Delirium is a serious neuropsychiatric syndrome in hospi-
talized patients, including those within palliative care set-
tings,1–3 and is associated with increased mortality.4,5 
Delirium impacts upon the patient’s ability to communi-
cate, their decision-making capacity, functional ability, and 
quality of life.1 Patients who recover from an episode of 
delirium usually recall the experience6,7 and report feeling 
frightened and humiliated.8 In the last days or hours of life, 
hyperactive delirium symptoms—commonly referred to as 
“terminal agitation” or “terminal restlessness”—cause dis-
tress for family members.9–11
Core symptoms for a Diagnostic and Statistical Manual 
(DSM), Fourth Edition (DSM-IV) diagnosis of delirium 
include disturbed consciousness, with reduced ability to 
focus, sustain, or shift attention; altered cognition or a per-
ceptual disturbance, acute onset and fluctuating symptoms, 
which can be mild and fleeting or severe and persistent; and 
evidence of an etiological cause.12 Level of consciousness 
identifies the three delirium subtypes: hyperactive, hypoac-
tive, or mixed.13 Lethargy, mood changes, and altered 
sleep–wake cycle can also occur, although are not required 
to establish a diagnosis.12
Despite numerous interventions for delirium reversal, 
management and support of palliative care patients with 
delirium being available, evidence of their effectiveness is 
evolving and requires further development.14–16 Identifying 
delirium is an important priority as approximately half of 
all delirium episodes are potentially reversible.4,17 
Iatrogenic causes, such as opioids and benzodiazepines, 
underscore the importance of recognition to modify pallia-
tive care interventions.18,19 Optimal recognition and assess-
ment of delirium is of clinical and ethical concern since 
sedation is commonly used to manage symptoms of rest-
lessness and agitation in the terminal stage.20,21 Under-
recognition of delirium results in interventions being 
inconsistently applied in palliative care.22–24
Screening improves clinician recognition of delirium,25 
yet is not routinely conducted in the inpatient palliative 
care setting.26 Previous reviews of delirium in palliative 
care settings have provided comprehensive examinations 
of the literature including delirium prevalence and assess-
ment methods,1,3,27 but to date, no reviews have examined 
in detail the methodological quality of delirium epidemio-
logical studies conducted in palliative care inpatient set-
tings, nor discussed implications of results in conjunction 
with other evidence required to justify implementation of 
routine delirium screening.28,29
Method
Aims and review processes
This systematic review aims to: (1) examine prevalence and 
incidence of delirium and delirium subtypes in 
specialist palliative care inpatient settings, at various stages 
of patients’ admission, (2) describe how delirium cases were 
identified and established in included studies, and (3) dis-
cuss results in relation to implementation of routine delirium 
screening in specialist palliative care inpatient units.
Although a meta-analysis of data was not undertaken, 
the Meta-Analysis of Observational Studies in Epide-
miology (MOOSE)30 guidelines were followed to facilitate 
systematic processes in the completion and reporting of the 
review, where relevant.
Search method
A systematic review was undertaken between 1 December 
2011 and 29 February 2012 and was limited to the studies 
published since 1980, when delirium was first identified 
within the DSM, Third Edition (DSM-III),31 up until early 
2012. Prospective search questions guided the search 
strategy using the following search Medical Subject 
Headings (MeSH) and key words, along with their associ-
ated derivatives: “delirium” OR “confusion” OR “termi-
nal agitation” OR “terminal restlessness” OR 
“psychomotor agitation” OR “cognitive failure” OR “dis-
orientation” AND “palliative care” OR “death” OR 
“dying” OR “terminal care” OR “hospice care” OR “ter-
minally ill” OR “end of life” AND “prevalence” OR “inci-
dence” OR “epidemiology”. Search engines used were 
Scopus, CINAHL, and Medline. In addition, the search 
terms “delirium” AND “prevalence” OR “incidence” OR 
“epidemiology” were employed in PubMed using the pal-
liative care filter from CareSearch.32 Reference lists of 
included studies and relevant reviews1,3 were also exam-
ined to search for other potentially eligible papers.
Study selection
Criteria for inclusion of papers were prospective assessment 
studies reporting prevalence, incidence, or rate of occur-
rence of delirium, conducted within specialist palliative care 
inpatient settings (defined as palliative care inpatient units 
or hospices) with adult participants. Studies were excluded 
if they were not published in English, or reported the rate of 
occurrence of symptoms or phenomena that were not 
specifically categorized as delirium, such as “cognitive 
failure,” “confusion,” or “terminal agitation,” as the inter-
changeable use of such terms has previously contributed to 
a lack of clarity in reporting and collating of delirium occur-
rence in palliative care populations.3 Two authors (A.H. and 
J.P.) examined the titles and abstracts of all papers to deter-
mine if they met the inclusion criteria, one author (A.H.) 
extracted the data from potentially relevant studies (n = 13) 








Assessment of methodological quality of 
included studies
The first author (A.H.) assessed the methodological 
quality of included studies with reference to the 
Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) guidelines33 and criteria 
developed by Boyle34 to evaluate prevalence studies, 
which were reviewed and confirmed by the other author 
(J.P.) as follows:
1. Sample:
a. Explanation of how the sample size was de-
termined;
b. Study population clearly defined;
c. Two-phase sampling process: delirium
screening followed by more comprehensive
delirium assessment;
d. Minimum of 80% participation within eli-
gible study population;
2. Measurement:
a. Standardized data collection methods for all
participants of the study;
b. Use of valid delirium-screening and assess-
ment tools AND/OR psychiatric assessment;
c. Reporting of measurement reliability process-
es, for example, user training in the delirium-
screening and assessment tool(s), inter-rater
reliability testing, supervision of clinical/re-
search staff conducting study measurements;
3. Analysis:
a. Confidence intervals included for statistical
analysis of frequency estimates.
Results
The initial search generated 815 papers: Scopus (n = 758), 
CINAHL (n = 28), Medline (n = 8), PubMed via CareSearch 
(n = 21). Within Scopus, adding “AND prospective study,” 
further refined the search and reduced the number of results 
within Scopus to 84 papers, resulting in 141 papers across 
all search engines. Once duplicates were removed, 119 
papers published between 1980 and 2011 remained (Figure 
1). A further 113 papers were removed as they did not 
report primary research data and/or prospectively measure 
prevalence or incidence rates of delirium in adult specialist 
palliative care inpatient units, leaving six papers. Two addi-
tional papers35,36 were identified from a hand search of the 
reference lists of the eligible papers and other reviews.1,3 At 
the end of the search, eight studies that prospectively meas-
ured the prevalence or incidence of delirium in specialist 
palliative care adult inpatient settings remained (Table 
1).4,5,35–37,39–41 These included studies which were con-
ducted in the northern hemisphere over a 12-year period 
(1996–2008).
Setting, diagnosis, and demographics
The included studies were undertaken in patient settings 
described variously as hospices (n = 2),39,41 palliative care 
units (n = 3),35–37 acute palliative care units (n = 2),4,40 and a 
combined acute palliative care unit/hospice (n = 1).5 Where 
described, the purpose of the settings included symptom 
control, respite, rehabilitation, and/or terminal care for pal-
liative care patients. The majority (98.9%) of all partici-
pants (n = 1079) across these studies had advanced cancer, 
with some diagnoses not specified in one study.41 Two stud-
ies included participants with other life limiting diseases: 
(a) immunodeficiency disorders (n = 11)36 and (b) end-stage 
cardiac failure and cerebrovascular disease (n = 1).41
Across the studies, there was equal representation of 
males and females, with a mean age of 66.24 years (range 
62–68.7 years). Participation rates varied (Table 1).
Study characteristics, design, quality, and focus
There was variability in study characteristics, design, qual-
ity, and foci, as well as participant numbers (X 120, range 
4140–228 people5). No studies reported statistical explana-
tions for determination of sample size, with this appearing 
to be largely determined by number of patient admissions 
within study periods. Delirium occurrence was measured at 
different frequencies and points of time during the admis-
sion, while five studies measured both delirium prevalence 
and incidence.4,35,36,39,41
Different criteria were used to define the terminal stage, 
with the last weeks of life considered the “pre-terminal and 
terminal” stage of cancer in two studies.5,39 “Terminally ill” 
or “terminal” cancer patients were elsewhere considered to 
be within the last 6 months of life.37 Only one study included 
the data specifically collected in the 6 hours immediately 
prior to death, defined as “terminal delirium.”4
Methodological quality of studies varied considerably 
and no study met all quality criteria (Table 1).
Definitions of delirium and diagnostic criteria used
Diagnostic criteria adopted by many of the studies, con-
ducted at different time points, reflect the evolution of the 
DSM diagnostic criteria for delirium. The majority (n = 6) 
of studies applied DSM criteria to diagnose delirium, with 
two using the research gold standard of psychiatrist assess-
ment to confirm delirium against the DSM version current 
at the time.5,37 In another four studies, diagnosis of delirium 
was based on the presence of the then-current DSM criteria, 
although not confirmed by psychiatric assessment.4,35,39,41 
The remaining two studies used an alternative criteria to 
establish a delirium diagnosis with one36 using the 
International Statistical Classification of Diseases and 
Related Health problems (ICD-10) Diagnostic Criteria for 
Research,42 which requires a greater range of symptoms to 






Screening and assessment tools
Eight different tools were used across the studies to assess 
cognition, screen for, or establish delirium (Table 1). Of the 
six delirium-specific screening or assessment tools, all var-
ied in their validity, purpose (screening, diagnosis, and 
severity), intended rater (psychiatrically vs nonpsychiatri-
cally trained), ratings procedures (observation vs inter-
view), number of items, and extent to which they correlate 
with different versions of DSM criteria for delirium.43,44
Three delirium or “confusion” screening tools included 
the Confusion Rating Scale (CRS) used by ward nurses39,45; 
Documents excluded after evaluation 
of abstract (n = 111)
• 73 - Not specifically
investigating delirium
• 15 - Delirium 
prevalence/incidence/issues in 
other populations (elderly 
inpatient (2); community (2);
hematology (2); ICU (4); hip 
fracture/surgery (2); long-term
care (2)
• 12 - Review article
• 6 - Retrospective study




2 documents excluded did not meet 
the inclusion criteria—both conducted 
retrospectively 
Potentially relevant documents identified by
literature search (n = 119)
Documents retrieved for detailed 
examination (n = 8)
Documents included in integrative
review (n = 6)
Total documents included in integrative 
review (n = 8)
Potentially relevant documents retrieved
by hand search (n = 5) 
3 documents excluded that did not 
meet the inclusion criteria 
• 1 conducted in an advanced 
cancer unit
• 1 non - specific definition of 
delirium
• 1 conducted retrospectively




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































admission to a palliative care unit found that delirium was 
the most prevalent psychiatric disorder, occurring in 28% of 
all participants and representing 52% of all psychiatric diag-
noses.37 Another study, using delirium screening during 
each 8-h shift, identified that 62% of participants developed 
delirium at some point during hospice admission.39 One 
study reassessed hospice patients (n = 73) 7 days after admis-
sion and found that 26% had delirium, while across 8 hos-
pices or inpatient palliative care services, 29.4% of patients 
had a delirium diagnosis during a 48-h period of assess-
ment.41 Recently, 46.9% of palliative care inpatients (n = 
228) screened second daily were found to have delirium.5
Three studies examined occurrence of delirium subtypes 
and all reported that the majority of delirious patients expe-
rienced hypoactive delirium (68%–86%).5,35,41
Five studies measured delirium incidence after admis-
sion and reported rates of between 3% and 45%.4,35,36,39,41 
Delirium developed during admission in 45% of patients (n 
= 60).4 In a later study involving 71 participants, 32.8% had 
confirmed delirium.39 These two studies included screening 
by ward nurses each 8-h shift.4,39 A study using daily screen-
ing reported, of admitted patients, 40.2% (n = 82) devel-
oped delirium (n = 33/82), the majority (70%) having 
hypoactive delirium of mild severity (53.3%).35 In contrast, 
one study reported development of five new cases in 73 
patients within a 7-day period, an incidence of 7%,41 while 
another, using twice weekly assessment and the ICD-10 
diagnostic criteria, reported an incidence of only 3%: dur-
ing the 6-month study period only 5 of 181 patients delir-
ium-free on admission subsequently developed delirium.36
Preceding death. Two studies measured prevalence of 
delirium in the weeks or hours before death, reporting rates 
of 58.8%–88%.4,35 The most recent study reported 58% 
delirium prevalence in patients (n = 51) who died during 
admission.35 Only one study explicitly measured and 
reported occurrence of delirium in the last 6 h of life in an 
Figure 2. Graphical representation of delirium prevalence and 
incidence rates in specialist palliative care inpatient units from 
results of included studies.
the Bedside Confusion Scale (BCS) used by medical inves-
tigators40,46; and the Delirium Observational Checklist 
Scale (DOCS), an instrument developed by study investi-
gators for ward nurse’s use.4 Although the BCS was previ-
ously validated in the palliative care setting, it requires 
further investigation of its psychometric properties.43 The 
CRS requires further validation, and the DOCS is not a 
validated delirium-screening tool.43
Two cognition assessment tools, used to either screen 
for delirium or to assist in delirium assessment, were the 
Mini-Mental State Examination (MMSE)47 used by psychi-
atric and medical investigators4,35,37,41 or clinical staff41 and 
the Blessed Orientation Memory Concentration (BOMC) 
test used by research nurses.39,48
Three delirium assessment tools were the Confusion 
Assessment Method (CAM)49 used by research nurses39 or 
medical investigators and trained clinical staff41; the 
Memorial Delirium Assessment Scale (MDAS)38,50 used by 
medical investigators,4,41 trained clinical staff,41 or a research 
nurse35; and the Delirium Rating Scale–Chinese Version 
(DRS-CV)51 used by a research nurse.5 Only the MDAS38,50 
and the Delirium Rating Scale (DRS)46,52,53 were validated 
in palliative care or advanced cancer populations prior to 
use in the studies under examination, with the MDAS under-
going further simultaneous validation.4,38,41 The CAM49 was 
validated in other clinical settings and languages,43 and sub-
sequently validated in the palliative care setting.54
No studies reported perspectives of patients or families 
of the acceptability of delirium-screening and assessment 
processes.
Delirium prevalence and incidence rates
The prevalence and incidence rates reported in the included 
studies are represented graphically in Figure 2.
On admission. Five studies measured delirium prevalence 
at admission, ranging from 13.3% to 42.3% of 
patients.4,36,39–41 Of 104 advanced cancer admissions to an 
acute palliative care unit, delirium was present at admission 
in 42.3% of patients.4 A later study, consecutively meas-
ured delirium frequency in hospice inpatients (n = 89) and 
13.3% were confirmed to have delirium.39 In another, 19% 
of patients (n = 224) admitted to a palliative care unit had 
delirium.36 A third (32%) of participants (n = 41) were clas-
sified as delirious according to presence of inattention and 
altered level of alertness in one acute palliative care unit,40 
while 29% of participating patients (n = 100) admitted to a 
Scottish hospice had delirium.41
During admission. Delirium prevalence across the whole 
cohort of palliative care inpatients during each study period 
ranged from 26% to 62%.5,37,39,41 One study measuring psy-







acute palliative care unit and found that the majority (88%) 
had delirium.4
Variation in delirium prevalence and incidence 
according to study methods and settings
Studies that used DSM-IV criteria reported higher delirium 
prevalence (42%–88%)4,5,35 and incidence (40.2%–
45%)4,35; compared to studies using earlier versions of 
DSM criteria and ICD-10 (prevalence 13.3%–29.4%36,37,39,41 
and incidence 3%–32.8%).36,39,41 Studies screening partici-
pants daily or more often reported higher delirium inci-
dence (32.8%–45%)4,35,39 than studies that screened or 
assessed delirium participants less frequently (3%–
7%).36,41 Delirium prevalence on admission varied slightly 
across settings: palliative care unit (19%), hospice (13.3%–
29%), and acute palliative care units (31.7%–42%).
Role of clinicians in the identification and 
diagnosis of delirium
In four studies, clinicians were actively involved in 
delirium screening and assessment study pro-
cesses.4,35,39,41 In two, ward nurses screened for delirium, 
using the DOCS4 or the CRS39 and received training in 
use of tools and features of delirium.39 In another, an 
experienced and trained nurse assessed delirious patients 
using the MDAS to measure delirium severity.35 In the 
study involving 8 separate Scottish hospices and pallia-
tive care services, clinicians received training prior to 
using the CAM and MDAS to identify and assess delirium 
over a 48-h period.41
Research nurses were also involved in delirium screening 
and assessment. The DRS-CV was used to screen inpatients 
for delirium,5 delirium diagnosis was established by nurses 
in another using the CAM in consultation with the psychiat-
ric investigator if there was uncertainty about the diagno-
sis,39 and delirium severity was measured by nurses using 
the MDAS 24 h after delirium diagnosis by a physician.35
Discussion
There were some similarities across studies, with most 
adopting a two-phase sampling method—delirium screen-
ing followed by assessment—and involving patients of a 
similar age and primary cancer diagnosis. However, there 
was a varying methodological quality across these studies, 
with heterogeneity of diagnostic criteria, sample sizes, fre-
quency of assessment, and measurement tools adopted. 
Despite these differences and the variation in reported 
delirium occurrence, categorizing delirium prevalence at 
different points along the palliative care inpatient trajectory 
indicates that prevalence is lower at admission (range 
13.3%–42.3%),4,36,39–41 increases during admission (range 
26%–62%),5,37,39,41 with the risk of developing delirium 
escalating as death nears (range 58.8%–88%).4,35 This 
review has confirmed that palliative care inpatient popula-
tions have delirium incidence and prevalence equal to or 
greater than other known high-risk populations, such as older 
people admitted to hospital,55 Intensive Care Units,56–58 post 
hip surgery,59,60 and long-term care.61
The review adds to the emerging evidence that hypoac-
tive delirium is the most prevalent subtype in palliative care 
populations.5,35,41,62 Hypoactive delirium may appear less 
severe than other subtypes35 and cause less difficulties in 
ward management,63 but is associated with increased mor-
tality.5 It also has a significant impact on patients and fami-
lies since cognitive changes occur as often as in the 
hyperactive and mixed subtypes.62,64
Clinicians were involved in patient screening and assess-
ment in half the studies, highlighting potential for routine 
delirium screening outside a research context, and feasibil-
ity of increasing delirium recognition capabilities by 
nonpsychiatric clinicians through training and access to 
validated delirium-screening and assessment tools.38,50,54 
Delirium screening by nurses in a hospice setting has been 
demonstrated to be feasible and effective.14,25 However, the 
challenges of screening for delirium in palliative care popu-
lations was also demonstrated by the small proportion of 
included studies measuring delirium occurrence specifi-
cally in cohorts of patients who were dying, and proportion 
of patients and/or families who declined to participate in 
the delirium assessment process, indicating delirium assess-
ment is not always acceptable to them. Additionally, many 
patients were too unwell to provide consent or were 
excluded because they were dying, comatose, or could not 
speak. Similarly, a recent study14 reported a low rate of 
CAM completion by hospice nurses (39%), highlighting 
the difficulty of conducting this delirium assessment in the 
last days of life and need for validated low-burden delirium 
assessment tools at this time.
Applying the DSM-IV criteria appears to lead to 
increased case finding, which has been previously 
reported65; and interestingly, variability in delirium preva-
lence and incidence noted in this review reflects results of 
similar reviews that included studies using less-specific 
delirium definitions.1,3
Implications for clinical practice and future research
As daily screening increases detection of incident delir-
ium,4,35,39 the question remains: should routine screening be 
implemented in palliative care inpatient settings? Clinical 
practice guidelines for other high-risk patient populations 
recommend screening to improve early recognition of 
delirium,55,66,67 although the extent to which this has been 
routinely adopted is unknown. However, a number of other 
key questions require investigation to justify routine screen-







family and cause minimal harm? Is it cost-effective? Does 
early recognition and treatment of delirium improve mor-
tality and morbidity? And, what are the adverse effects of 
delirium treatment?28,29
Further research in delirium prevention interventions in 
palliative care,14 and high-level evidence of the efficacy and 
safety of pharmacological interventions, such as antipsy-
chotics, benzodiazepines, and methylphenidate, is 
needed.16,68,69 Measuring impact of interventions on delir-
ium incidence, severity, and patient mortality should con-
tinue to be a focus of research, but as improvements in 
morbidity and mortality are likely to be minimal in this 
population and the focus of care is a relief of distress and 
suffering, patients’ and families’ subjective experiences 
(such as perceptions of care, distress, dignity, and quality of 
life) related to delirium screening, recognition, and treat-
ment are especially important outcomes to be determined.70 
Development of acceptable, observational delirium screen-
ing and assessment strategies for palliative care patients 
who are very ill, dying, or unable to communicate is also 
required.8,28,29
This review has highlighted the lack of consensus 
regarding selection of delirium screening and assessment 
tools in palliative care research, and this is likely to be 
reflected in clinical practice. Establishing the acceptability 
of various delirium-screening and assessment tools by 
patients and families would inform the sector about which 
are the most appropriate to use in this population, particu-
larly in the dying stage. Establishing consensus would 
facilitate delirium benchmarking, quality improvement,71,72 
and consistency of research methodology. To further 
improve methodological and reporting quality of future 
delirium epidemiological research in palliative care popu-
lations, consideration of recently developed guidelines for 
observational studies in epidemiology is recommended.33,73
Health-economic analysis will also be an important 
inclusion in future delirium research, when high health-
care costs associated with delirium occurrence in elderly 
inpatient populations is considered.74,75
Study limitations and strengths
Limitations of this review include exclusion of papers not 
published in English, potentially contributing to selection 
bias and the absence of multiple independent raters in the 
extraction of data to assess eligibility and quality of 
included studies. There are limitations related to generaliz-
ability of this review due to the focus on advanced cancer 
diagnoses within study populations.70 As the brief of pallia-
tive care shifts to nonmalignant conditions and settings 
where end-of-life care is routinely provided, for example, 
elderly medical inpatient settings or nursing homes, it is 
important to consider implications of this changing popula-
tion.76–78 In addition, although results suggest increasing 
delirium prevalence as death nears, this was not confirmed 
within this review due to variable reporting of participants’ 
functional status and illness staging, and variation in opera-
tional definitions of “terminal.” This barrier has been previ-
ously noted with a recommendation that all future delirium 
occurrence studies incorporate a patient cohort classifica-
tion system based on estimated prognosis.3
The strengths of this review include use of a systematic 
approach, with application of accepted guidelines and a 
structured approach to the assessment of quality of included 
studies.30,33
Conclusion
This review has examined methods, quality, and results of 
studies prospectively measuring delirium occurrence in 
specialist palliative care inpatient settings and identified 
additional evidence needed to justify routine delirium 
screening in these settings. While the moderate to high rate 
of delirium occurrence in palliative care inpatient units sup-
ports the need for delirium screening, there is also a need to 
develop consensus and quality of methods for measuring 
delirium occurrence, and we require evidence regarding 
impact, acceptability, potential harms and cost-effective-
ness of delirium screening and assessment, and outcomes 
of screening and treatments on morbidity, mortality, and 
patients’ and families’ subjective experiences.
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